This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yasen, M. Articles by Hino, O. Search for Related Content PubMed PubMed Citation Articles by Yasen, M. Articles by Hino, O.

The Up-Regulation of Y-Box Binding Proteins (DNA Binding Protein A and Y-Box Binding Protein-1) as Prognostic Markers of Hepatocellular Carcinoma

Authors' Affiliations: ¹ Second Department of Pathology, Juntendo University School of Medicine, Tokyo, Japan; ² Department of Hepato-Biliary-Pancreatic Surgery, Tokyo Medical and Dental University, Tokyo, Japan; ³ Department of Surgery, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan; ⁴ Department of Molecular Biology, University of Occupational and Environmental Health, Fukuoka, Japan; and ⁵ Immuno-Biological Laboratories Co., Ltd., Gunma, Japan

Requests for reprints: Okio Hino, Second Department of Pathology, Juntendo University School of Medicine, 2-1-1, Bunkyo-ku, Hongo, 113-8421 Tokyo, Japan. Phone: 81-3-5802-1038; Fax: 81-3-5684-1646; E-mail: ohino{at}med.juntendo.ac.jp.

Purpose: The development of hepatocellular carcinoma is associated with the chronic inflammation of the liver caused by various factors such as hepatitis B or C virus infection. Previously, we reported DNA binding protein A (dbpA) as a candidate molecule that can accelerate inflammation-induced hepatocarcinogenesis. DbpA belongs to the Y-box binding protein family, and Y-box binding protein-1 (YB-1), the prototype member of this family, is reported to be a prognostic marker of malignant diseases other than hepatocellular carcinoma. The purpose of this study is to examine the significance of the expression of dbpA or of the T-to-G transversion in the dbpA promoter region, which enhances the promoter activity in vitro, for the progression of hepatocellular carcinoma.

Experimental Design: We studied the expression of dbpA (as well as of YB-1) in 82 formalin-fixed hepatocellular carcinoma tissues by immunohistochemistry and determined the sequence of the dbpA promoter region in 42 frozen hepatocellular carcinoma tissues. We examined the relationship between these findings and the clinicopathologic factors of hepatocellular carcinoma patients.

Results: DbpA expression was associated with the advanced stages of hepatocellular carcinoma, and the cases with the nuclear dbpA expression had a poor prognosis. DbpA contributed more significantly to this association than YB-1. Furthermore, the T-to-G transversion in the dbpA promoter region was related to the nuclear localization of dbpA.

Conclusion: DbpA was a more significant prognostic marker of hepatocellular carcinoma than YB-1. The T-to-G transversion in the dbpA promoter region was suggested to be a predisposing factor for the progression of hepatocellular carcinoma.

This article has been cited by other articles:

				S. M. Paranjape and E. Harris Y Box-binding Protein-1 Binds to the Dengue Virus 3'-Untranslated Region and Mediates Antiviral Effects J. Biol. Chem., October 19, 2007; 282(42): 30497 - 30508. [Abstract] [Full Text] [PDF]

				Z. H. Lu, J. T. Books, and T. J. Ley Cold Shock Domain Family Members YB-1 and MSY4 Share Essential Functions during Murine Embryogenesis Mol. Cell. Biol., November 15, 2006; 26(22): 8410 - 8417. [Abstract] [Full Text] [PDF]